openPR Logo
Press release

Angiotensin-Converting Enzyme (ACE) Inhibitors Industry is Expected to Reach Huge Growth by 2031 - Camber Pharmaceuticals, Inc., Pfizer Inc, Merck & Co., Inc, Biogaran, Lupin Pharmaceuticals, Inc

08-12-2024 12:03 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Angiotensin-Converting Enzyme (ACE) Inhibitors Industry

DataM Intelligence has published a new research report on "Angiotensin-Converting Enzyme (ACE) Inhibitors Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/angiotensin-converting-enzyme-inhibitors-market

The Angiotensin-Converting Enzyme (ACE) Inhibitors market report majorly focuses on market trends, historical growth rates, technologies, and the changing investment structure. Additionally, the report shows the latest market insights, increasing growth opportunities, business strategies, and growth plans adopted by major players. Moreover, it contains an analysis of current market dynamics, future developments, and Porter's Five Forces Analysis.

Angiotensin-Converting Enzyme (ACE) Inhibitors are a class of medications primarily used to treat high blood pressure (hypertension) and heart failure. They work by blocking the action of the enzyme angiotensin-converting enzyme, which is responsible for the production of angiotensin II, a substance that narrows blood vessels and increases blood pressure. By inhibiting this enzyme, ACE inhibitors help to relax blood vessels, lower blood pressure, and reduce the workload on the heart. These medications are also used to prevent kidney damage in people with diabetes and to improve survival rates in patients who have experienced a heart attack. Common examples of ACE inhibitors include lisinopril, enalapril, and ramipril.

Forecast Growth Projected:

The Global Angiotensin-Converting Enzyme (ACE) Inhibitors Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

List of the Key Players in the Angiotensin-Converting Enzyme (ACE) Inhibitors Market:

Camber Pharmaceuticals, Inc., Pfizer Inc, Merck & Co., Inc, Biogaran, Lupin Pharmaceuticals, Inc., Crescent Pharma Limited, Global Pharma Pvt Ltd, SCHWITZ BIOTECH, Steris Healthcare PVT Ltd, Auro Pharma Inc

Segment Covered in the Angiotensin-Converting Enzyme (ACE) Inhibitors Market:

By Drug Type: Dicarboxylate-containing Agents, Enalapril, Ramipril, Quinapril, Others, Phosphonate-containing Agents, Fosinopril, Others, Sulfhydryl-containing Agents, Alacepril, Captopril, Others

By Application: Cardiovascular Diseases, Renal Diseases, Diabetes, Hypertension, Others

By Route of Administration: Oral, Parenteral, Others

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Regional Analysis:

The global Angiotensin-Converting Enzyme (ACE) Inhibitors Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/angiotensin-converting-enzyme-inhibitors-market

Regional Analysis:

The global Angiotensin-Converting Enzyme (ACE) Inhibitors Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Angiotensin-Converting Enzyme (ACE) Inhibitors Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Angiotensin-Converting Enzyme (ACE) Inhibitors manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Revenue of Angiotensin-Converting Enzyme (ACE) Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.

Get a Free Sample PDF copy of the report @ https://datamintelligence.com/download-sample/angiotensin-converting-enzyme-inhibitors-market

Read Latest Blog: https://www.datamintelligence.com/blogs/top-10-process-automation-companies-worldwide

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Angiotensin-Converting Enzyme (ACE) Inhibitors Industry is Expected to Reach Huge Growth by 2031 - Camber Pharmaceuticals, Inc., Pfizer Inc, Merck & Co., Inc, Biogaran, Lupin Pharmaceuticals, Inc here

News-ID: 3619496 • Views:

More Releases from DataM intelligence 4 Market Research LLP

United States Legal AI Software Market to Reach USD 3.7 Billion by 2030, Driven by Automation and Efficiency Demands | DataM Intelligence
United States Legal AI Software Market to Reach USD 3.7 Billion by 2030, Driven …
The global Legal AI Software Market reached USD 0.5 billion in 2022 and is projected to reach USD 3.7 billion by 2030, growing at a CAGR of 28.7% during the forecast period 2024-2031, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, Thomson Reuters launched its next-generation AI contract review platform, reducing document analysis time by 80% for corporate legal teams. ✅ In August 2025, A coalition of top
United States AI In Renewable Energy Market to Reach USD 4.85 Billion by 2032, Driven by Grid Optimization and Predictive Maintenance | DataM Intelligence
United States AI In Renewable Energy Market to Reach USD 4.85 Billion by 2032, D …
The global AI In Renewable Energy Market reached US$ 0.85 billion in 2024 and is projected to reach US$ 4.85 billion by 2032, growing at a CAGR of 24.32% during the forecast period 2025-2032, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, The National Renewable Energy Laboratory (NREL) launched an AI platform that improved solar generation forecasts by 30%, significantly enhancing grid reliability. ✅ In August 2025,
United States AI In Energy Market Projected to Expand at 33.45% CAGR, Reaching US$ 99.48 billion by 2032 | DataM Intelligence
United States AI In Energy Market Projected to Expand at 33.45% CAGR, Reaching U …
The global AI In Energy Market reached US$ 9.89 billion in 2024 and is projected to reach US$ 99.48 billion by 2032, growing at a CAGR of 33.45% during the forecast period 2025-2032, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, Google DeepMind partnered with a major US utility to implement AI for real-time grid optimization, reducing energy losses by 15%. ✅ In
United States Allergy Immunotherapies Market 2025 | Growth Drivers, Trends & Market Forecast, Competitive Landscape & Investment Opportunities
United States Allergy Immunotherapies Market 2025 | Growth Drivers, Trends & Mar …
Market Size and Growth The "Global Allergy Immunotherapies Market" is predicted to reach at a high CAGR of 10.4% during the forecast period (2022-2029) Key Development: United States: Recent Industry Developments ✅ In September 2025, Sanofi expanded its allergy immunotherapy portfolio by acquiring Ayvakit and early-stage immunology assets for USD 9.1 billion, enhancing its position in severe allergic conditions. ✅ In June 2025, BioVaxys Technology Corp. launched a private placement to raise USD 1.2-1.6

All 5 Releases


More Releases for ACE

ChillReleaf Cooling Ace Reviews: Coolizi Cooling Ace, The Top Rated Portable Air …
As temperatures rise and the summer sun blazes on, staying cool without racking up high electricity bills has become a growing concern for many households. Enter the Coolizi Cooling Ace, also known as the ChillReleaf Cooling Ace - a game-changing portable cooling solution designed for modern comfort and efficiency. This compact, lightweight, and stylish device delivers powerful cooling performance without the bulk or complexity of traditional air conditioners. Whether you're
Coolizi cooling Ace reviews - Coolizi Cooling Ace portable air cooler
[United States] - June 2025 - With record-breaking temperatures sweeping across the U.S., consumers are turning to smart cooling solutions that are effective, affordable, and energy-efficient. One product standing out from the crowd is the Coolizi Cooling Ace - a compact, powerful portable air cooler that's already gone viral online. From TikTok to tech blogs, the buzz around Coolizi Cooling Ace Reviews is growing rapidly, and for good reason. Click Below
ChillReleaf Cooling Ace Reviews 2025
Introduction In the sweltering heat of summer, finding an efficient and affordable cooling solution becomes paramount. The ChillReleaf Cooling Ace positions itself as a portable, energy-efficient alternative to traditional air conditioning units. Marketed as a bladeless, whisper-quiet device capable of cooling the air by up to 20°F in just 30 seconds, it promises rapid relief without the hefty electricity bills associated with conventional ACs . Design and Build Quality The Cooling Ace boasts
Coldeez Cooling ACE Australia (Updated): Don't Buy Coldeez Cooling ACE In Austra …
Not long ago, Coldeez Cooling ACE was designed and immediately made available for sales in Australia, mainly on the official website at discounted prices. Like most portable air coolers, many people have been questioning its authenticity despite being one of the best selling portable air coolers in Australia. It is so amazing how fast it has gone viral despite being relatively new and the competition from some top brands. Based
ACE Health Solutions Goes Live
ACE Health Solutions (AHS), a full-service consulting company enabling independent physicians and multi-specialty clinics to optimize business practices, launched in late 2012. Since the launch, AHS has been working with local practices helping them implement electronic medical records (EMR) services and providing an array of other services. J. Chawla, ACE’s CEO and Founder, who has several years of experience working for successful healthcare organizations, is quoted in saying “the healthcare
Ace Appliance Repair
Ace Appliance Repair, an appliance repair service in Pittsburgh, PA, recently partnered with Prospect Genius, an online marketing firm, to assist area homeowners searching for low-priced appliance repairs. Through targeted search engine optimization (SEO) tactics, ACE Appliance repair is making it easier and quicker for local homeowners to locate them when performing Internet searches for appliance repair services and other needs, such as water heater installation. Joe Sazio, owner and founder